 | Up a level |
Küchlin, Sebastian; Ihorst, Gabriele; Heinrich, Sven P; Márquez Neila, Pablo; Albrecht, Philipp; Hug, Martin J; Lagrèze, Wolf A (2024). Visual Pathway Outcomes Based on Sample Size in Clinical Neuroprotection Research. JAMA neurology, 81(5), pp. 553-554. American Medical Association 10.1001/jamaneurol.2024.0462
Küchlin, Sebastian; Ihorst, Gabriele; Heinrich, Sven P; Márquez Neila, Pablo; Albrecht, Philipp; Hug, Martin J; Diem, Ricarda; Lagrèze, Wolf A (2024). Disease Course of Clinically Isolated Optic Neuritis. Neurology: Neuroimmunology and Neuroinflammation, 11(3) Wolters Kluwer Health 10.1212/NXI.0000000000200223
Küchlin, Sebastian; Ihorst, Gabriele; Grotejohann, Birgit; Beisse, Flemming; Heinrich, Sven P; Albrecht, Philipp; Ungewiss, Judith; Wörner, Michael; Hug, Martin J; Wolf, Sebastian; Diem, Ricarda; Lagrèze, Wolf A (2023). Treatment With Erythropoietin for Patients With Optic Neuritis: Long-term Follow-up. Neurology: Neuroimmunology and Neuroinflammation, 10(4) Wolters Kluwer Health 10.1212/NXI.0000000000200067
Lagrèze, Wolf A; Küchlin, Sebastian; Ihorst, Gabriele; Grotejohann, Birgit; Beisse, Flemming; Volkmann, Martin; Heinrich, Sven P; Albrecht, Philipp; Ungewiss, Judith; Wörner, Michael; Hug, Martin J; Wolf, Sebastian; Diem, Ricarda (2021). Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study. The lancet. Neurology, 20(12), pp. 991-1000. Elsevier 10.1016/S1474-4422(21)00322-7
Iking-Konert, Christof; Wallmeier, Pia; Arnold, Sabrina; Adler, Sabine; de Groot, Kirsten; Hellmich, Bernhard; Hoyer, Bimba F; Holl-Ulrich, Konstanze; Ihorst, Gabriele; Kaufmann, Margit; Kötter, Ina; Müller-Ladner, Ulf; Magnus, T; Rech, Jürgen; Schubach, Fabian; Schulze-Koops, Hendrik; Venhoff, Nils; Wiech, Thorsten; Villiger, Peter and Lamprecht, Peter (2021). The Joint Vasculitis Registry in German-speaking countries (GeVas) - a prospective, multicenter registry for the follow-up of long-term outcomes in vasculitis. BMC rheumatology, 5(1), p. 40. BioMed Central 10.1186/s41927-021-00206-2
Mathew, Nimitha R; Baumgartner, Francis; Braun, Lukas; O'Sullivan, David; Thomas, Simone; Waterhouse, Miguel; Müller, Tony A; Hanke, Kathrin; Taromi, Sanaz; Apostolova, Petya; Illert, Anna L; Melchinger, Wolfgang; Duquesne, Sandra; Schmitt-Graeff, Annette; Osswald, Lena; Yan, Kai-Li; Weber, Arnim; Tugues, Sonia; Spath, Sabine; Pfeifer, Dietmar; ... (2018). Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nature medicine, 24(3), pp. 282-291. Nature Publishing Group 10.1038/nm.4484
Diem, Ricarda; Molnar, Fanni; Beisse, Flemming; Gross, Nikolai; Drüschler, Katharina; Heinrich, Sven P; Joachimsen, Lutz; Rauer, Sebastian; Pielen, Amelie; Sühs, Kurt-Wolfram; Linker, Ralf Andreas; Huchzermeyer, Cord; Albrecht, Philipp; Hassenstein, Andrea; Aktas, Orhan; Guthoff, Tanja; Tonagel, Felix; Kernstock, Christoph; Hartmann, Kathrin; Kümpfel, Tania; ... (2016). Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol. BMJ open, 6(3), e010956. BMJ Publishing Group 10.1136/bmjopen-2015-010956
